Home Cart Sign in  
Chemical Structure| 2729996-45-4 Chemical Structure| 2729996-45-4

Structure of GNE-9815
CAS No.: 2729996-45-4

Chemical Structure| 2729996-45-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GNE-9815 is a potent, highly selective, pan-RAF inhibitor with excellent oral bioavailability. It shows Ki values of 0.062 nM for CRAF and 0.19 nM for BRAF. GNE-9815, in combination with the MEK inhibitor Cobimetinib, effectively modulates the MAPK pathway, making it suitable for research on KRAS mutant cancers.

Synonyms: GNE-9815

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GNE-9815

CAS No. :2729996-45-4
Formula : C26H22FN5O2
M.W : 455.48
SMILES Code : N#CC(C=1C=CC=C(C1)C(=O)NC=2C=C(C3=CN=C4C(C=NN(C4=O)C)=C3)C(=CC2F)C)(C)C
Synonyms :
GNE-9815
MDL No. :N/A

Safety of GNE-9815

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of GNE-9815

MAPK

Isoform Comparison

Biological Activity

Description
GNE-9815 is a potent, highly selective, pan-RAF inhibitor with excellent oral bioavailability. It shows Ki values of 0.062 nM for CRAF and 0.19 nM for BRAF. GNE-9815, in combination with the MEK inhibitor Cobimetinib, effectively modulates the MAPK pathway, making it suitable for research on KRAS mutant cancers[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.20mL

0.44mL

0.22mL

10.98mL

2.20mL

1.10mL

21.95mL

4.39mL

2.20mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories